From: A field evaluation of two vaccines against Mycoplasma hyopneumoniae infection in pigs
Herd | A | B | ||||
---|---|---|---|---|---|---|
Treatment group | ThoroVAX®VET | Ingelvac®MycoFLEX | Control | ThoroVAX®VET | Ingelvac®MycoFLEX | Control |
N* lungs obtained | 285 | 283 | 299 | 324 | 306 | 334 |
N uncomplicated catarrhal pneumonia (%) | 130b | 152a | 161a** | 51b | 104a | 127a (38.0) |
(45.6) | (53.7) | *(53.9) | (15.7) | (34.0) | ||
N complicated catarrhal pneumonia (%) | 0 | 2 | 4 | 1 | 8 | 1 |
(0) | (0.7) | (1.3) | (0.3) | (2.6) | (0.3) | |
N fissures (%) | 53a (18.6) | 53a (18.7) | 50a (16.7) | 63b (19.4) | 86a (28.1) | 104a (31.1) |
N of pigs with at least one M. hyopneumoniae like lung lesion (%) | 156b (54.7) | 171a (60.4) | 189a (63.2) | 105b (32.4) | 159a ( 52.0) | 185a (55.4) |
Volume (%) (sd)*** | 9.0b | 10.7a | 11.9a | 6.3b | 8.6a | 9.0a |
(7.1) | (8.4) | (9.1) | (4.4) | (6.7) | (7.6) |